Merck ends development of Parkinson's disease drug
1 day ago
Merck says it reviewed initial data from three late-stage clinical trials and did not find evidence preladenant was more effective than a placebo.
FDA has safety concerns on Merck insomnia drug
4 days ago
Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.
7-20-2002: The king of con | News | News from Fort Worth, Dallas, Arlington,...
10 days ago
"What they've found is just the tip of the iceberg," he says of the revelations at Enron, WorldCom and ImClone, among others.
Lawsuit alleges Merck discriminates against women
15 days ago
She wants to create a class action lawsuit on behalf of Merck's female sales representatives.
Merck: FDA reviewing its ragweed allergy therapy
16 days ago
Merck's latest application is for an allergy immunotherapy tablet for ragweed allergies that dissolves under the tongue.
News Summary: Generic rivals hurt Merck results
23 days ago
ON DECK: Merck has five drugs under review by regulators, including a promising insomnia medicine called suvorexant.
Stocks fall on jobs concerns, fall in Merck profit
23 days ago
The stock market is falling early after a survey showed U.S. companies added the fewest jobs in seven months and Merck reported a lower quarterly profit.
Generic competition cuts Merck's Q1 sales, profit
23 days ago
Merck's first-quarter profit fell 8.3 percent and revenue by 9 percent, mainly because competition from generics slashed sales of its top seller, asthma and allergy drug Singulair.
News Summary: Merck names ex-Amgen exec to run R&D
78 days ago
COMING BACK: Dr. Roger Perlmutter, a former research executive at drugmaker Merck & Co., will return on April 15 to become director of Merck Research Laboratories.
Merck replacing R&D head with former company exec
78 days ago
The world's third-biggest drugmaker by revenue says Dr. Roger Perlmutter, a former research executive at Merck and Amgen Inc., will begin running Merck Research Laboratories on April 15.
